SEC Filing Summary: PerkinElmer, Inc. (10-Q)
Business Context and Reporting Period
This is a Quarterly Report on Form 10-Q for PerkinElmer, Inc. (Note: The request metadata lists "REVVITY, INC.", but the filing text identifies the registrant as PerkinElmer, Inc.). The report covers the quarterly period ended September 26, 2004, and the nine-month period ended on that date. PerkinElmer operates in three reporting segments: Life and Analytical Sciences, Optoelectronics, and Fluid Sciences. The company is a leading provider of scientific instruments, consumables, and services to pharmaceutical, biomedical, environmental, and industrial markets.
Key Financial Metrics
| Metric | Three Months Ended Sept 26, 2004 |
Three Months Ended Sept 28, 2003 |
Nine Months Ended Sept 26, 2004 |
Nine Months Ended Sept 28, 2003 |
|---|---|---|---|---|
| Sales (Revenue) | $403.4 million | $366.2 million | $1,208.6 million | $1,100.2 million |
| Operating Income | $42.9 million | $34.9 million | $112.9 million | $86.4 million |
| Net Income | $24.0 million | $14.3 million | $58.1 million | $25.0 million |
| Diluted EPS | $0.19 | $0.11 | $0.45 | $0.20 |
| Gross Margin | 39.7% | 41.8% | 39.7% | 40.5% |
| Operating Cash Flow | N/A | N/A | $129.7 million | $89.6 million |
| Cash and Equivalents | $220.0 million | N/A | $220.0 million | N/A |
| Total Debt | $474.5 million | N/A | $474.5 million | N/A |
Note: Total debt includes $170.0 million in term loan principal, $300.0 million in 8 7/8% notes, and $4.7 million in 6.8% notes.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 10% year-over-year for both the quarter and the nine-month period. Growth was driven by the Fluid Sciences segment (+39%), Optoelectronics (+13%), and Life and Analytical Sciences (+4%). Foreign exchange rates (primarily the Euro) contributed approximately $9.2 million to quarterly sales and $34.5 million to nine-month sales.
- Profitability: Net income increased significantly (68% for the quarter, 132% for nine months). Operating income rose 23% for the quarter and 31% for the nine-month period.
- Margin Compression: Gross margin decreased 210 basis points for the quarter and 80 basis points for the nine-month period. This was primarily due to a higher sales mix from the Fluid Sciences segment, which has lower gross margins but also lower operating expenses.
- Discontinued Operations: The company recorded losses from discontinued operations, including the shutdown of the Computer-To-Plate business ($1.4 million write-down) and the Electroformed Products business ($1.2 million loss). These were offset by a $1.5 million gain on contract settlements related to the former Technical Services business.
- Debt Reduction: The company repaid $75.0 million of its term loan principal during the nine-month period, reducing total debt obligations.
Guidance, Outlook, and Risks
- Restructuring: The company is executing four restructuring plans initiated between 2001 and 2003. Remaining liabilities for severance and facility abandonment are expected to be settled by the end of 2004 or 2005. The company targets combined pre-tax cost savings of $30 million to $45 million in fiscal 2004 relative to 2002 levels.
- Capital Expenditures: Expected to range between $15.0 million and $20.0 million for fiscal 2004, dependent on economic conditions.
- Legal Proceedings: The company is defending against a class action lawsuit (filed 2002) and derivative lawsuits (filed 2004) alleging misleading statements regarding prospects and operating results. Management believes it has meritorious defenses but cannot estimate potential losses.
- Environmental Contingencies: An accrual of $4.3 million exists for environmental remediation. While a material loss exceeding this amount is possible, management does not expect the exposure to be materially different from recorded amounts.
- Market Risks: Significant exposure to foreign currency fluctuations (over 50% of sales are international) and interest rate changes on variable-rate debt. The company uses interest rate swaps to hedge $100 million of fixed-rate notes.
Investor Verification Checklist
- Segment Mix Impact: Verify the sustainability of the Fluid Sciences growth (+39%) and its impact on consolidated gross margins.
- Discontinued Operations: Confirm the final costs associated with the Computer-To-Plate and Electroformed Products shutdowns.
- Legal Exposure: Monitor the status of the class action and derivative lawsuits for any material settlement risks.
- Debt Covenants: Review compliance with financial ratios in the senior credit facility and 8 7/8% notes indenture, particularly regarding leverage and interest coverage.
- Foreign Exchange Sensitivity: Assess the impact of future Euro and other currency fluctuations on reported revenue and earnings.